Work

Cost-Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States

Year: 2017

Type: article

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.4703.4703

Authors: Eytan M. Stein, Jipan Xie, Emilie Duchesneau, S. Bhattacharyya, Briana Ndife, Gaetano Bonifacio, George J Joseph

Institutions: Memorial Sloan Kettering Cancer Center, Analysis Group (United States), Novartis (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2939834166

FWCI:

Cites:

Cited by:

Related to: 20